Tozorakimab-placebo, Tozorakimab, SALBUTAMOL
D9181C00002
Phase 2 small_molecule active
Quick answer
Tozorakimab-placebo, Tozorakimab, SALBUTAMOL for Asthma is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Asthma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active